Evidence map›Paper›PMID 33773752›Full record

ArticleBiological psychiatry2021

The PI3-Kinase p110β Isoform Controls Severity of Cocaine-Induced Sequelae and Alters the Striatal Transcriptome.

Lauren P Shapiro, Elizabeth G Pitts, Dan C Li, Britton R Barbee, Elizabeth A Hinton, Gary J Bassell, Christina Gross, Shannon L Gourley

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lauren P ShapiroGraduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia.
Elizabeth G PittsGraduate Program in Neuroscience, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia.
Dan C LiGraduate Program in Neuroscience, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia.
Britton R BarbeeGraduate Program in Molecular and Systems Pharmacology, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia.
Elizabeth A HintonGraduate Program in Neuroscience, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia.
Gary J BassellGraduate Program in Neuroscience, Emory University, Atlanta, Georgia; Department of Cell Biology, Emory University, Atlanta, Georgia.
Christina GrossDivision of Neurology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Shannon L GourleyGraduate Program in Neuroscience, Emory University, Atlanta, Georgia; Yerkes National Primate Research Center, The Robert W. Woodruff Health Sciences Center, Emory University, Atlanta, Georgia; Department of Pediatrics, Emory School of Medicine, Emory University, Atlanta, Georgia; Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: shannon.l.gourley@emory.edu.
Emory University · USCincinnati Children's Hospital Medical Center · USEmory Healthcare · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2008 to 2018
$6.8M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Neurotrophic and ontogenic factors in medial orbitofrontal cortical functionR01DA044297 · NIDA · EMORY UNIVERSITY · PI Shannon Leigh Gourley · 2018 to 2026
$3.7M
Selective targeting of P13K to restore higher cognitive function in FXSR21MH103748 · NIMH · CINCINNATI CHILDRENS HOSP MED CTR · PI GROSS, CHRISTINA · 2014 to 2015
$461k
NIDA NIH HHS R01 DA044297NIGMS NIH HHS T32 GM008169NIGMS NIH HHS T32 GM008602NIH HHS P51 OD011132NIMH NIH HHS R21 MH103748NINDS NIH HHS P30 NS055077
6 · The paper itself

Abstract

backgroundThe PI3-kinase (PI3K) complex is a well-validated target for mitigating cocaine-elicited sequelae, but pan-PI3K inhibitors are not viable long-term treatment options. The PI3K complex is composed of p110 catalytic and regulatory subunits, which can be individually manipulated for therapeutic purposes. However, this possibility has largely not been explored in behavioral contexts.

methodsHere, we inhibited PI3K p110β in the medial prefrontal cortex (mPFC) of cocaine-exposed mice. Behavioral models for studying relapse, sensitization, and decision-making biases were paired with protein quantification, RNA sequencing, and cell type-specific chemogenetic manipulation and RNA quantification to determine whether and how inhibiting PI3K p110β confers resilience to cocaine.

resultsViral-mediated PI3K p110β silencing reduced cue-induced reinstatement of cocaine seeking by half, blocked locomotor sensitization, and restored mPFC synaptic marker content after exposure to cocaine. Cocaine blocked the ability of mice to select actions based on their consequences, and p110β inhibition restored this ability. Silencing dopamine D

conclusionsSubunit-selective PI3K silencing potently mitigates drug seeking, sensitization, and decision-making biases after exposure to cocaine. We suggest that inhibiting PI3K p110β provides neuroprotection against cocaine by triggering coordinated corticostriatal adaptations.

Indexed as

CocaineAnimalsMicePhosphatidylinositol 3-KinasesPrefrontal CortexProtein IsoformsRatsRats, Sprague-DawleyTranscriptomeCocainePhosphatidylinositol 3-KinasesProtein IsoformsAction-outcomeAddictionGoalIncentivePrelimbicPsychostimulantReward

Identifiers

PMID33773752
PMCPMC8202243
OpenAlexW3124503084

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.